Serascience gets EU green light for world’s first POC blood cancer test
This article was originally published in Clinica
A point-of-care test for multiple myeloma, said to be the first of its kind, is poised to hit the EU markets, following the CE marking of the product by its UK developer Serascience.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.